| 1. |
張琦穎, 申璐, 楊文昌, 等. Sorsby眼底營養不良一家系2例[J]. 中華眼底病雜志, 2023, 39(7): 588-590. DOI: 10.3760/cma.j.cn511434-20220328-00173.Zhang QY, Shen L, Yang WC, et al. There were 2 cases of fundus dystrophy in Sorsby's family[J]. Chin J Ocul Fundus Dis, 2023, 39(7): 588-590. DOI: 10.3760/cma.j.cn511434-20220328-00173.
|
| 2. |
Hristova R, Veleva N, Oscar A, et al. TIMP3 c. 319C>T, p. (Arg107Cys): novel sequence variant in Sorsby fundus dystrophy[J]. Nepal J Ophthalmol, 2024, 16(31): 87-93. DOI: 10.3126/nepjoph.v16i1.63004.
|
| 3. |
Gómez-Benlloch A, Garrell-Salat X, Cobos E, et al. Optical coherence tomography in inherited macular dystrophies: a review[J/OL]. Diagnostics (Basel), 2024, 14(9): 878[2024-04-24]. https://pubmed.ncbi.nlm.nih.gov/38732293/. DOI: 10.3390/diagnostics14090878.
|
| 4. |
Vergaro A, Pankievic M, Jedlickova J, et al. Disease-causing TIMP3 variants and deep phenotyping of two czech families with Sorsby fundus dystrophy associated with novel p. (Tyr152Cys) mutation[J/OL]. Int J Mol Sci, 2024, 25(7): 3744[2024-04-27]. https://pubmed.ncbi.nlm.nih.gov/38612555/. DOI: 10.3390/ijms25073744.
|
| 5. |
Tsokolas G. Sorsby fundus dystrophy (SFD): a narrative review[J/OL]. Medicine (Baltimore), 2022, 101(38): e30595[2022-09-23]. https://pubmed.ncbi.nlm.nih.gov/36197222/. DOI: 10.1097/MD.0000000000030595.
|
| 6. |
Iyer PG, Zhou H, Zhang Q, et al. Swept-source optical coherence tomography detection of Bruch membrane and choriocapillaris abnormalities in Sorsby macular dystrophy[J/OL]. Retina, 2022, 42(9): 1645-1654. DOI: 10.1097/IAE.0000000000003515.
|
| 7. |
古秋梅, 陳正舉, 肖林, 等. Sorsby眼底營養不良的系統評價[J]. 中華眼底病雜志, 2022, 38(11): 925-930. DOI: 10.3760/cma.j.cn511434-20220614-00359.Gu QM, Chen ZG, Xiao L, et al. Sorsby's fundus dystrophy: a systematic review[J]. Chin J Ocul Fundus Dis, 2022, 38(11): 925-930. DOI: 10.3760/cma.j.cn511434-20220614-00359.
|
| 8. |
Anand-Apte B, Chao JR, Singh R, et al. Sorsby fundus dystrophy: Insights from the past and looking to the future[J]. J Neurosci Res, 2019, 97(1): 88-97. DOI: 10.1002/jnr.24317.
|
| 9. |
Dewing JM, Carare RO, Lotery AJ, et al. The diverse roles of TIMP-3: insights into degenerative diseases of the senescent retina and brain[J/OL]. Cells, 2019, 9(1): 39[2019-12-21]. https://pubmed.ncbi.nlm.nih.gov/31877820/. DOI: 10.3390/cells9010039.
|
| 10. |
Greenstein VC, Nunez J, Lee W, et al. A comparison of en face optical coherence tomography and fundus autofluorescence in Stargardt disease[J]. Invest Ophthalmol Vis Sci, 2017, 58(12): 5227-5236. DOI: 10.1167/iovs.17-22532.
|
| 11. |
Baston A, Gerhardt C, Zandi S, et al. Visual outcome after intravitreal anti-VEGF therapy for macular neovascularisation secondary to Sorsby’s fundus dystrophy: a systematic review[J/OL]. J Clin Med, 2021, 10(11): 2433[2021-05-30]. https://pubmed.ncbi.nlm.nih.gov/34070857/. DOI: 10.3390/jcm10112433.
|
| 12. |
Spaide RF. Long-term visual acuity preservation in Sorsby fundus dystrophy with corticosteroid treatment[J]. Retin Cases Brief Rep, 2022, 16(1): 44-47. DOI: 10.1097/ICB.0000000000000946.
|
| 13. |
Spaide RF. Treatment of Sorsby fundus dystrophy with anti-tumor necrosis factor-alpha medication[J]. Eye (Lond), 2022, 36(9): 1810-1812. DOI: 10.1038/s41433-021-01735-3.
|
| 14. |
Elsayed MEAA, Kaukonen M, Kiraly P, et al. Potential CRISPR base editing therapeutic options in a Sorsby fundus dystrophy patient[J/OL]. Genes (Basel), 2022, 13(11): 2103[2022-11-12]. https://pubmed.ncbi.nlm.nih.gov/36421778/. DOI: 10.3390/genes13112103.
|
